Live feed
·
INSIDERFilingvia Quantisnow
Context Therapeutics Inc. logo

Context Therapeutics (CNTX): SEC Form 4: Lehr Martin A. bought $4,901 worth of shares (6,839 units at $0.72), increasing direct ownership by 5% to 136,205 units

ByQuantisnow·Wall Street's wire, on your screen.
Stocks in this Quantisnow insight
Quantisnow market dataNASDAQ
Context Therapeutics Inc. logo
CNTX
Context Therapeutics Inc.
Market cap
30-day
Sector
Health Care
Industry
Biotechnology: Pharmaceutical Preparations
Listed since
2021
Get push alerts for CNTX

Follow CNTX and get a push notification the moment its next story breaks.

Full CNTX profile on Quantisnow
Original source Picked up and delivered by Quantisnow in real time

This insight was delivered by - Wall Street's wire, on your screen. Quantisnow is a real-time market data and news platform for retail investors, aggregating SEC filings, FDA approvals, analyst ratings, insider trading, and press releases into a single customizable feed. Track CNTX (Context Therapeutics Inc.) and more on Quantisnow.